| Pharmaceutical active ingredients: |
| Eucalyptus OilPine Sylvestris Oil |
| Available forms, composition and doses of Melrosum Inhalationstropfen: |
| N / A |
| Melrosum Inhalationstropfen medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05X - Other cold combination preparations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisCassella-Med |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Melrosum | Thyme | Sanofi-Aventis; Cassella-Med |
| Melrosum Codein Hustensirup | Codeine Phosphate | Sanofi-Aventis; Cassella-Med |
| Melrosum Extra Sterk | Codeine Phosphate; Vegetable Extracts | Sanofi-Aventis |
| Melrosum Hustensirup | Thyme | Sanofi-Aventis; Cassella-Med |
| Melrosum Hustensirup N | Burnet Saxifrage; Grindelia; Primula Root; Rose Petals; Thyme | Sanofi-Aventis |
| Melrosum Medizinalbad | Pine Sylvestris Oil; Thyme Oil | Sanofi-Aventis; Cassella-Med |
| Memoserina S | DL-Phosphoserine; Glutamine; Protein Hydrolysate; Vitamin B12 (Cyanocobalamin) | Sanofi-Aventis |
| Menactra | Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group A; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group C; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group W 135; Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate, Group Y | Sanofi-Aventis; Zuellig Pharma |
| Mengivac A + C | Meningococcal Vaccine, inactivated, groups A and C Polysaccharide | Sanofi-Aventis |
| Meningo A + C | Meningococcal Vaccine groups A, C | Sanofi-Aventis |